Capricor Therapeutics's total assets for Q2 2025 were $133.57B, an increase of 86765.13% from the previous quarter. CAPR total liabilities were $194.60M for the fiscal quarter, a 645.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.